在门诊瘤环境中实施网络支持的癌症和衰老弹性评估 (WeCARE)
Christian Harmon1, Mackenzie Fowler1, Smith Giri2
1Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
Journal of geriatric oncology
|October 8, 2023
概括
网络支持的老年诊断评估 (WeCARE) 成功地融入瘤学,大多数老年癌症患者在预约前完成了这些评估. 需要进一步努力,以确保提供者充分利用治疗决策的数据.
科学领域:
- 老年瘤学 老年瘤学
- 医疗信息学 医疗信息学
- 实施科学 实施科学
背景情况:
- 建议老年癌症患者进行老年评估 (GA),但未得到充分利用.
- 在日常的瘤实践中,GA整合的障碍仍然存在.
- 需要新的交付方法来改善GA的实施.
研究的目的:
- 评估在胃肠道 (GI) 瘤诊所实施网络支持的老年病学评估 (WeCARE) 工具的实施情况.
- 评估患者完成率和WeCARE系统的提供者可用性.
- 确定将WeCARE整合到临床工作流程中的挑战和促进者.
主要方法:
- 一项单一机构的研究,涉及老年患者 (≥60岁) 患有肠道恶性瘤,正在接受初次医疗瘤诊断.
- 患者在预约前通过电子方式获得了WeCARE GA的链接.
- 提供商的可用性通过调查进行评估.
主要成果:
- 在266名符合条件的患者中,有200名 (75.2%) 在访问前完成了WeCARE.
- 大多数患者更喜欢电子邮件而不是文本来进行调查.
- 虽然提供者发现该工具是可行的,但只有三分之一的人在治疗决策中始终使用仪表板.
结论:
- 网络支持的老年医学评估 (WeCARE) 是一个有希望的可行方法,可以克服GA在瘤学中的实施障碍.
- 高的患者完成率是通过最小的员工支持实现的.
- 需要进一步的战略来加强提供商的采用,并将WeCARE数据有意义地纳入临床实践.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
相关概念视频
Cancer Survival Analysis
365
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
365
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Nursing Evaluation
3.4K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Documentation in Long-Term and Home Healthcare Setting
902
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
902
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
